COEXPRESSION OF WILD-TYPE AND VARIANT ESTROGEN-RECEPTOR MESSENGER-RNAS IN A PANEL OF HUMAN BREAST-CANCER CELL-LINES

被引:25
作者
CASTLES, CG
KLOTZ, DM
FUQUA, SAW
HILL, SM
机构
[1] TULANE UNIV,SCH MED,MOLEC & CELLULAR BIOL GRAD PROGRAM,NEW ORLEANS,LA 70112
[2] TULANE UNIV,SCH MED,TULANE CANC CTR,NEW ORLEANS,LA 70112
[3] TULANE UNIV,SCH MED,DEPT ANAT,NEW ORLEANS,LA 70112
[4] UNIV TEXAS,HLTH SCI CTR,DEPT MED ONCOL,SAN ANTONIO,TX 78284
关键词
ESTROGEN RECEPTORS; VARIANTS; BREAST CANCER CELL LINES;
D O I
10.1038/bjc.1995.188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Wild-type as well as variant oestrogen receptor (ER) mRNAs with exon 5 and 7 deleted were identified in a panel of human breast tumour cell lines by reverse transcriptase-polymerase chain reaction followed by dideoxynucleotide sequence analysis, and then quantitated by ribonuclease protection analysis. All cell lines categorised as ER(+) by ligand-binding analysis expressed both wild-type and variant ER transcripts. Most cell lines classified as ER(-) did not express any ER transcript. However, three ER cell lines (BT-20, MDA-MB-330 and T47D(co)) expressed both wild-type and variant transcripts. A differential pattern of expression of wild type to variant was seen in both ER(+) and ER(-) cell lines, however this pattern was not paralleled by differences in ligand-binding activity. Breast tumour cell lines previously classified as ER(-) expressed significantly lower levels of ER transcripts than did their ER(+) counterparts. In view of these findings, as well as earlier reports that the exon 5 deletion ER variant encodes a dominant-positive receptor, it seems clear that some cell lines are misclassified as ER(-), and express both wild-type and variant ER mRNAs, and that the overexpression of this variant may account, in part, for their oestrogen-independent phenotype.
引用
收藏
页码:974 / 980
页数:7
相关论文
共 29 条
  • [1] STEROID-RECEPTORS, CELLULAR KINETICS, AND LYMPH-NODE STATUS AS PROGNOSTIC FACTORS IN BREAST-CANCER
    BENNER, SE
    CLARK, GM
    MCGUIRE, WL
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (01) : 59 - 66
  • [2] CASTLES CG, 1993, CANCER RES, V53, P5934
  • [3] SUPERCOIL SEQUENCING - A FAST AND SIMPLE METHOD FOR SEQUENCING PLASMID DNA
    CHEN, EY
    SEEBURG, PH
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1985, 4 (02): : 165 - 170
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] ESTROGEN AND PROGESTERONE-RECEPTOR PROTEINS IN BREAST-CANCER
    EDWARDS, DP
    CHAMNESS, GC
    MCGUIRE, WL
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 560 (04) : 457 - 486
  • [6] THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY
    EVANS, RM
    [J]. SCIENCE, 1988, 240 (4854) : 889 - 895
  • [7] CHARACTERIZATION AND COLOCALIZATION OF STEROID BINDING AND DIMERIZATION ACTIVITIES IN THE MOUSE ESTROGEN-RECEPTOR
    FAWELL, SE
    LEES, JA
    WHITE, R
    PARKER, MG
    [J]. CELL, 1990, 60 (06) : 953 - 962
  • [8] THE ER-POSITIVE PGR-NEGATIVE BREAST-CANCER PHENOTYPE IS NOT ASSOCIATED WITH MUTATIONS WITHIN THE DNA-BINDING DOMAIN
    FUQUA, SAW
    ALLRED, DC
    ELLEDGE, RM
    KRIEG, SL
    BENEDIX, MG
    NAWAZ, Z
    OMALLEY, BW
    GREENE, GL
    MCGUIRE, WL
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (02) : 191 - 202
  • [9] FUQUA SAW, 1991, CANCER RES, V51, P105
  • [10] FUQUA SAW, 1992, CANCER RES, V52, P483